BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohamed HB, Abd El-Hamid BN, Fathalla D, Fouad EA. Current trends in pharmaceutical treatment of Dry Eye Disease: A review. Eur J Pharm Sci 2022;:106206. [PMID: 35568107 DOI: 10.1016/j.ejps.2022.106206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Scarpellini C, Ramos Llorca A, Lanthier C, Klejborowska G, Augustyns K. The Potential Role of Regulated Cell Death in Dry Eye Diseases and Ocular Surface Dysfunction. Int J Mol Sci 2023;24. [PMID: 36614174 DOI: 10.3390/ijms24010731] [Reference Citation Analysis]
2 Borgia A, Raimondi R, Fossati G, De Rosa FP, Romano V, Borroni D, Vigo L, Scorcia V, Giannaccare G. Device-based therapies as a boost of conventional treatment in dry eye disease. Expert Review of Ophthalmology 2022. [DOI: 10.1080/17469899.2022.2147928] [Reference Citation Analysis]
3 Srinivasan S, Williams R. Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease. Clin Ophthalmol 2022;16:3311-26. [PMID: 36237486 DOI: 10.2147/OPTH.S377960] [Reference Citation Analysis]
4 Mallis P, Michalopoulos E, Sarri EF, Papadopoulou E, Theodoropoulou V, Katsimpoulas M, Stavropoulos-giokas C. Evaluation of the Regenerative Potential of Platelet-Lysate and Platelet-Poor Plasma Derived from the Cord Blood Units in Corneal Wound Healing Applications: An In Vitro Comparative Study on Corneal Epithelial Cells. CIMB 2022;44:4415-4438. [DOI: 10.3390/cimb44100303] [Reference Citation Analysis]